Verona names Biresh Roy CFO
This article was originally published in Scrip
Verona Pharma, a drug development company focused on first-in-class medicines to treat respiratory diseases, has appointed Biresh Roy chief financial officer and a member of its board of directors – effective immediately. He takes over from Richard Bungay, whose appointment was part-time and a non-board role. Prior to joining Cardiff, Wales-based Verona Mr Roy founded Ebury Capital and Growth Solutions, a professional services and investment boutique focused on executing change and investing in AIM and privately backed companies.
You may also be interested in...
A rush in the 2010s of high-tech and digital companies focused on women’s health and wellbeing are maturing, adding weight to the more traditional women's health market that has struggled to get attention from investors in the past.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
A selection of articles you might have missed from September 2020, including exclusive interviews with industry leaders and a review of value-based contract approaches in the US.